Literature DB >> 7768372

Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel.

S Reif1, I Klein, N Arber, T Gilat.   

Abstract

BACKGROUND/AIMS: An excess of smokers in patients with Crohn's disease (CD) and a paucity of smokers in patients with ulcerative colitis (UC) were reported in many studies. The aim of this study was to examine the association between smoking and inflammatory bowel disease (IBD) in Israel.
METHODS: Two independent studies were performed. Patients with recent IBD in comparison with matched population and outpatient controls and patients with chronic UC and CD were studied. Altogether, 475 subjects were investigated.
RESULTS: In both studies, the presence of current smokers was lower in CD (9% and 18%) than in UC (24% and 26%). The proportions of nonsmokers in both studies were similar (UC, 61% and 65%; CD, 67% and 70%) and comparable to those found in their two control groups (57% and 61%; 63% and 68%, respectively) and to the general population of Israel. All differences in smoking habits between patient groups and their controls were not statistically significant, except for the paucity of current smokers in the small group of patients with newly diagnosed CD (P < 0.05). A matched analysis produced similar results.
CONCLUSIONS: The expected associations between smoking and IBD could not be confirmed. Two hypotheses are considered: (1) the association between smoking and IBD may not be universal, and (2) our findings may be related to the higher genetic predisposition to IBD in Jewish people.

Entities:  

Mesh:

Year:  1995        PMID: 7768372     DOI: 10.1016/0016-5085(95)90129-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

Review 2.  Effect of smoking on inflammatory bowel disease: Is it disease or organ specific?

Authors:  A Karban; R Eliakim
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

3.  Pre-illness dietary factors in inflammatory bowel disease.

Authors:  S Reif; I Klein; F Lubin; M Farbstein; A Hallak; T Gilat
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

Review 4.  The impact of smoking in Crohn's disease: no smoke without fire.

Authors:  Marian C Aldhous; J Satsangi
Journal:  Frontline Gastroenterol       Date:  2010-09-23

5.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

6.  Passive smoking and inflammatory bowel disease: a meta-analysis.

Authors:  Deborah T Jones; Mark T Osterman; Meenakshi Bewtra; James D Lewis
Journal:  Am J Gastroenterol       Date:  2008-09       Impact factor: 10.864

7.  Crohn's disease in adults: observations in a multiracial Asian population.

Authors:  Ida Hilmi; Y M Tan; K L Goh
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

8.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

9.  Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA.

Authors:  Peiqi Wang; Jun Hu; Shadi Ghadermarzi; Ali Raza; Douglas O'Connell; Amy Xiao; Faraz Ayyaz; Min Zhi; Yuanqi Zhang; Nimisha K Parekh; Mark Lazarev; Alyssa Parian; Steven R Brant; Marshall Bedine; Brindusa Truta; Pinjin Hu; Rupa Banerjee; Susan M Hutfless
Journal:  Dig Dis Sci       Date:  2018-06-04       Impact factor: 3.199

10.  The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa.

Authors:  Tawanda Chivese; Tonya M Esterhuizen; Abigail Raffner Basson; Gillian Watermeyer
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.